[go: up one dir, main page]

TR201819348T4 - Otizm Bozukluklarının Mentol, Linalool ve/veya İsilin İle Tedavisi ya da Önlenmesi - Google Patents

Otizm Bozukluklarının Mentol, Linalool ve/veya İsilin İle Tedavisi ya da Önlenmesi Download PDF

Info

Publication number
TR201819348T4
TR201819348T4 TR2018/19348T TR201819348T TR201819348T4 TR 201819348 T4 TR201819348 T4 TR 201819348T4 TR 2018/19348 T TR2018/19348 T TR 2018/19348T TR 201819348 T TR201819348 T TR 201819348T TR 201819348 T4 TR201819348 T4 TR 201819348T4
Authority
TR
Turkey
Prior art keywords
linalool
menthol
isilla
prevention
treatment
Prior art date
Application number
TR2018/19348T
Other languages
English (en)
Inventor
Camacho Susana
Michlig Gonzalez Stéphanie
Le Coutre Johannes
Pezzoli Maurizio
Markram Henry
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of TR201819348T4 publication Critical patent/TR201819348T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Physiology (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Bir otizm bozukluğunun tedavisi ya da önlenmesinde kullanım için kompozisyonlar sağlanmaktadır ve kompozisyonlar, Mentol, Linalool, İsilin ve bunların birleşimlerinden oluşan bir bileşiğin terapötik olarak etkili bir miktarını ihtiva eder. Otizm bozukluklarının tedavisi ya da önlenmesi için yöntemler de sağlanmaktadır ve yöntemler bu kompozisyonların uygulanmasını içerir.
TR2018/19348T 2013-05-24 2014-05-23 Otizm Bozukluklarının Mentol, Linalool ve/veya İsilin İle Tedavisi ya da Önlenmesi TR201819348T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361827229P 2013-05-24 2013-05-24

Publications (1)

Publication Number Publication Date
TR201819348T4 true TR201819348T4 (tr) 2019-01-21

Family

ID=50819729

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2018/19348T TR201819348T4 (tr) 2013-05-24 2014-05-23 Otizm Bozukluklarının Mentol, Linalool ve/veya İsilin İle Tedavisi ya da Önlenmesi

Country Status (10)

Country Link
US (2) US10369151B2 (tr)
EP (1) EP3003293B1 (tr)
JP (2) JP2016520589A (tr)
CN (3) CN115006399B (tr)
AU (1) AU2014270342C1 (tr)
BR (1) BR112015026533A2 (tr)
CA (1) CA2908348C (tr)
ES (1) ES2701324T3 (tr)
TR (1) TR201819348T4 (tr)
WO (1) WO2014187946A1 (tr)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3633699B2 (ja) 1995-12-28 2005-03-30 株式会社資生堂 コエンドロ抽出物の使用
US6472378B2 (en) * 1998-08-31 2002-10-29 Pro-Neuron, Inc. Compositions and methods for treatment of mitochondrial diseases
US6528076B2 (en) * 2001-07-06 2003-03-04 Magic Herb Corp. Topical compositions and methods for treating pain
GB0229811D0 (en) * 2002-12-20 2003-01-29 Unilever Plc Compound delivery systems
WO2006029142A2 (en) * 2004-09-02 2006-03-16 University Of Florida Research Foundation, Inc. Methods and systems for treating asthma and other respiratory diseases
JP2006199662A (ja) 2005-01-24 2006-08-03 Kodera Herb Garden:Kk 自閉症改善薬の製法
US8058243B2 (en) * 2006-10-13 2011-11-15 Hsc Research And Development Limited Partnership Method for treating a brain cancer with ifenprodil
WO2008095297A1 (en) * 2007-02-06 2008-08-14 Origin Biomed Inc. Composition comprising terpene compounds and methods for inhibiting nerve transmission
EP2236042A1 (en) * 2009-03-30 2010-10-06 Nestec S.A. Fresh citrus juice and a method for preparing the same
JP5388759B2 (ja) 2009-08-27 2014-01-15 美智士 谷 自閉症の改善薬、治療茶
CA2785056A1 (en) * 2009-12-22 2011-07-21 Pondera Biotechnologies, LLC Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications
KR20120103317A (ko) 2011-03-10 2012-09-19 한국생명공학연구원 아실 코에이:콜레스테롤 아실트랜스퍼라제 저해활성을 갖는 고수씨 추출물 또는 이로부터 분리된 리나로올을 포함하는 조성물
CN102240280A (zh) * 2011-04-29 2011-11-16 李光武 一种经嗅觉通路脑靶向防治高血压及调节内脏功能芳香精油类的药物组合物
JP5867598B2 (ja) * 2011-05-26 2016-02-24 谷 亞紀子 自閉症の治療薬
GB201110546D0 (en) * 2011-06-22 2011-08-03 Imp Innovations Ltd Compositions
CN102258751A (zh) * 2011-07-21 2011-11-30 泰一和浦（北京）中医药研究院有限公司 用于治疗忧郁症、消愁解忧、善解抑郁的中药薄荷

Also Published As

Publication number Publication date
CN115006399B (zh) 2024-04-05
CN110151766B (zh) 2022-08-16
JP2019131601A (ja) 2019-08-08
CN110151766A (zh) 2019-08-23
CA2908348A1 (en) 2014-11-27
US20190307748A1 (en) 2019-10-10
EP3003293B1 (en) 2018-10-17
AU2014270342C1 (en) 2019-12-19
CN105228600B (zh) 2019-08-30
WO2014187946A1 (en) 2014-11-27
EP3003293A1 (en) 2016-04-13
US10369151B2 (en) 2019-08-06
ES2701324T3 (es) 2019-02-21
JP2016520589A (ja) 2016-07-14
US11241433B2 (en) 2022-02-08
CN105228600A (zh) 2016-01-06
CN115006399A (zh) 2022-09-06
CA2908348C (en) 2021-05-25
AU2014270342B2 (en) 2019-09-12
BR112015026533A2 (pt) 2017-07-25
US20160089370A1 (en) 2016-03-31
AU2014270342A1 (en) 2015-10-08

Similar Documents

Publication Publication Date Title
CY1125144T1 (el) Φαρμακευτικη συνθεση, μεθοδοι θεραπειας και χρηση αυτης
EA201591674A1 (ru) Противораковые вакцины и способы лечения с их применением
CL2015002472A1 (es) Como inhibidores de mutant idh-yl-oxazolidin-2-onas 3-pirimidin-4.
CR20150376A (es) Compuestos sustituidos de pirrolopirimidina, compuestos de los mismos y metodos de tratamiento con los mismos
EA201690980A1 (ru) Комбинированная терапия, включающая ингибитор mdm2 и один или более дополнительных фармацевтически активных агентов, для лечения различных видов рака
CL2018000222A1 (es) Nueva combinación para el uso en el tratamiento del cáncer
BR112015011830A2 (pt) compostos e seus métodos de utilização
BR112016014410A2 (pt) terapia de combinação com vacina de neoantígeno
MX378273B (es) Compuestos activos hacia bromodominios.
MX356368B (es) Profarmacos de fumaratos y su uso en el tratamiento de diferentes enfermedades.
MX2017007321A (es) Terapias de combinacion.
BR112015027282A2 (pt) fenfluramina para uso no tratamento de síndrome de dravet
MX2020009780A (es) Compuestos de inhibidor de autotaxina.
WO2013177187A3 (en) Synergistic tumor treatment with extended-pk il-2 and therapeutic agents
EA201590880A1 (ru) Композиции и способы лечения протеинопатий
BR112015011756A2 (pt) inibidores da glutamase e métodos de uso
MX2015014589A (es) Tratamiento de cancer con dihidropirazino-pirazinas.
EA201591925A1 (ru) Терапевтические композиции и их применение
MX2015014599A (es) Terapia de combinacion que comprende un inhibidor de tor cinasa y un analogo de citidina para tracar cancer.
EA201891514A1 (ru) Комбинированная терапия ингибитором бромодомена и экстратерминального белка
CL2015003595A1 (es) Inhibidores/antiandrógenos novedosos de cyp17
ECSP14011792A (es) Inhibidores de iap
CL2015001202A1 (es) Compuestos derivados de oxazolidin-2-ona-pirimidina; composicion y combinacion farmaceutica y uso en el tratamiento del cancer.
PH12015501002A1 (en) Treatment of cancer with pomalidomide in a renally impaired subject
MX377510B (es) Uso de levocetirizina y montelukast en el tratamiento de anafilaxis.